BDSX vs. CRNC
BDSX (Biodesix, Inc.) and CRNC (Cerence Inc.) are both stocks. BDSX operates in Diagnostics & Research (Healthcare), while CRNC operates in Software - Application (Technology). Over the past 5 years, BDSX returned -42.92%/yr vs -35.25%/yr for CRNC. At a 0.18 correlation, their price movements are largely independent.
Performance
BDSX vs. CRNC - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, BDSX achieves a 142.65% return, which is significantly higher than CRNC's 15.34% return.
BDSX
- 1D
- 2.48%
- 1M
- 10.44%
- YTD
- 142.65%
- 6M
- 93.21%
- 1Y
- 178.53%
- 3Y*
- -16.36%
- 5Y*
- -42.92%
- 10Y*
- —
CRNC
- 1D
- 0.41%
- 1M
- 25.05%
- YTD
- 15.34%
- 6M
- -4.79%
- 1Y
- 26.85%
- 3Y*
- -24.28%
- 5Y*
- -35.25%
- 10Y*
- —
BDSX vs. CRNC - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|---|
BDSX Biodesix, Inc. | 142.65% | -77.78% | -16.85% | -20.00% | -56.52% | -73.76% | 57.38% |
CRNC Cerence Inc. | 15.34% | 36.18% | -60.07% | 6.10% | -75.82% | -23.73% | 73.42% |
Correlation
The correlation between BDSX and CRNC is 0.09, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.09 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.13 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.17 |
Correlation (All Time) Calculated using the full available price history since Oct 29, 2020 | 0.18 |
Fundamentals
BDSX:
$159.32M
CRNC:
$578.26M
BDSX:
-$3.93
CRNC:
-$0.44
BDSX:
1.40
CRNC:
1.82
BDSX:
17.45
CRNC:
3.65
BDSX:
$96.10M
CRNC:
$302.14M
BDSX:
$57.53M
CRNC:
$235.95M
BDSX:
-$20.16M
CRNC:
$34.08M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
BDSX vs. CRNC — Risk / Return Rank
BDSX
CRNC
BDSX vs. CRNC - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Biodesix, Inc. (BDSX) and Cerence Inc. (CRNC). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| BDSX | CRNC | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +1.26 | ||
| Sortino ratioReturn per unit of downside risk | +1.50 | ||
| Omega ratioGain probability vs. loss probability | 1.30 | 1.13 | +0.17 |
| Calmar ratioReturn relative to maximum drawdown | 3.65 | 0.48 | +3.16 |
| Martin ratioReturn relative to average drawdown | 7.59 | 1.01 | +6.58 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| BDSX | CRNC | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 1.57 | 0.31 | +1.26 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | -0.42 | -0.31 | -0.11 |
Sharpe Ratio (All Time)Calculated using the full available price history | -0.38 | -0.03 | -0.35 |
Drawdowns
BDSX vs. CRNC - Drawdown Comparison
The maximum BDSX drawdown since its inception was -99.30%, roughly equal to the maximum CRNC drawdown of -98.22%. Use the drawdown chart below to compare losses from any high point for BDSX and CRNC.
Loading charts...
Drawdown Indicators
| BDSX | CRNC | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -99.30% | -98.22% | -1.08% |
Max Drawdown (1Y)Largest decline over 1 year | -49.28% | -55.92% | +6.64% |
Max Drawdown (3Y)Largest decline over 3 years | -89.67% | -93.25% | +3.58% |
Max Drawdown (5Y)Largest decline over 5 years | -98.63% | -98.09% | -0.54% |
Current DrawdownCurrent decline from peak | -97.36% | -90.76% | -6.60% |
Average DrawdownAverage peak-to-trough decline | -85.73% | -62.97% | -22.76% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 23.63% | 26.78% | -3.15% |
Volatility
BDSX vs. CRNC - Volatility Comparison
The current volatility for Biodesix, Inc. (BDSX) is 17.35%, while Cerence Inc. (CRNC) has a volatility of 22.33%. This indicates that BDSX experiences smaller price fluctuations and is considered to be less risky than CRNC based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| BDSX | CRNC | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 17.35% | 22.33% | -4.98% |
Volatility (6M)Calculated over the trailing 6-month period | 81.55% | 56.54% | +25.01% |
Volatility (1Y)Calculated over the trailing 1-year period | 114.51% | 86.31% | +28.20% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 102.97% | 113.49% | -10.52% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 101.96% | 106.36% | -4.40% |
Dividends
BDSX vs. CRNC - Dividend Comparison
Neither BDSX nor CRNC has paid dividends to shareholders.
Financials
BDSX vs. CRNC - Financials Comparison
This section allows you to compare key financial metrics between Biodesix, Inc. and Cerence Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
BDSX vs. CRNC - Profitability Comparison
BDSX - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Biodesix, Inc. reported a gross profit of 0.00 and revenue of 25.56M. Therefore, the gross margin over that period was 0.0%.
CRNC - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Cerence Inc. reported a gross profit of 47.30M and revenue of 64.19M. Therefore, the gross margin over that period was 73.7%.
BDSX - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Biodesix, Inc. reported an operating income of -6.20M and revenue of 25.56M, resulting in an operating margin of -24.3%.
CRNC - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Cerence Inc. reported an operating income of -2.44M and revenue of 64.19M, resulting in an operating margin of -3.8%.
BDSX - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Biodesix, Inc. reported a net income of -7.79M and revenue of 25.56M, resulting in a net margin of -30.5%.
CRNC - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Cerence Inc. reported a net income of 1.67M and revenue of 64.19M, resulting in a net margin of 2.6%.
Frequently Asked Questions
BDSX and CRNC have a correlation of 0.09, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
CRNC has higher volatility (22.33%) compared to BDSX (17.35%). In terms of maximum drawdown, BDSX dropped -99.30% vs CRNC's -98.22%.
BDSX currently has the higher Sharpe Ratio (1.57 vs 0.31), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for BDSX and CRNC
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer